Skip to search
Skip to main content
Back to Search
Start Over
Multicenter, phase III, open-label, randomized study in relapsed/refractory CLI, to evaluate the benefit of GDC-0199 (ABT-199) plus rituximah compared with bendamustine plus rituximab.
Authors :
Mobasher, Mehrdad Huang, Jane Elstrom, Rebecca L. Elhamy, Mostafa Bernaards, Coen Hallek, Michael J. Hillmen, Peter Kater, Arnon Philip Kipps, Thomas J. Seymour, John Francis Mobasher, Mehrdad Huang, Jane Elstrom, Rebecca L. Elhamy, Mostafa Bernaards, Coen Hallek, Michael J. Hillmen, Peter Kater, Arnon Philip Kipps, Thomas J. Seymour, John Francis
Publication Year :
2014
Details
Database :
OAIster
Notes :
English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1247374374
Document Type :
Electronic Resource